|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1997; 30:1052-1056 © 1997 by the American College of Cardiology Foundation |
Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, USA.
OBJECTIVES: The present study was designed to assess the impact of direct current shocks on cardiac troponin I (cTnI), which has greater sensitivity and specificity than creatine kinase (CK) for the diagnosis of myocardial injury. BACKGROUND: Transthoracic direct current shocks can cause myocardial injury. They also cause elevations of total CK and CK-MB fraction (CK-MB). METHODS: We obtained measurements of cTnI total CK and CK-MB before and after elective cardioversions in 38 patients. Blood samples were drawn before and 8, 16, 24 and 48 h after cardioversion. Shock energy, current, impedance and number of shocks delivered were tabulated. RESULTS: Patients received a mean (+/-SD) of 2.1 +/- 1.2 shocks with a median cumulative energy of 300 J (range 50 to 1,580). Three patients had minimal elevations (1.5, 1.2 and 0.8 ng/ml, normal < or = 0.6 ng/ml) of cTnI. Two of these patients had impaired left ventricular contractility by echocardiography. Thirty-five of the 38 patients had no elevations of cTnI. Sixty-two percent of patients had an increase in CK after cardioversion, but CK-MB was elevated to an abnormal level of 12.7 ng/ml (normal < 6.7) in only one patient after cardioversion. CONCLUSIONS: Cardiac troponin I levels are either normal or minimally elevated after elective direct current cardioversion, suggesting that subtle myocardial injury can be caused by direct current transthoracic shocks. However, substantial elevations of cTnI after cardioversion suggest the presence of myocardial injury from causes unrelated to the direct current shocks administered for cardioversion.
This article has been cited by other articles:
|
|
 |
|
  M. H. Raitt Implantable Cardioverter-Defibrillator Shocks: A Double-Edged Sword? J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1366 - 1368. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Simon, A. Roscitano, F. Capuano, U. Benedetto, G. Di Nucci, E. Tonelli, and R. Sinatra Effect of topic defibrillation on serum markers of myocardial damage Interactive CardioVascular and Thoracic Surgery, February 1, 2006; 5(1): 75 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Babuin and A. S. Jaffe Troponin: the biomarker of choice for the detection of cardiac injury Can. Med. Assoc. J., November 8, 2005; 173(10): 1191 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Gatzoulis, G. K. Andrikopoulos, T. Apostolopoulos, E. Sotiropoulos, G. Zervopoulos, J. Antoniou, S. Brili, and C. I. Stefanadis Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy Europace, January 1, 2005; 7(2): 184 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Goktekin, M. Melek, B. Gorenek, A. Birdane, G. Kudaiberdieva, Y. Cavusoglu, and B. Timuralp Cardiac Troponin T and Cardiac Enzymes After External Transthoracic Cardioversion of Ventricular Arrhythmias in Patients With Coronary Artery Disease Chest, December 1, 2002; 122(6): 2050 - 2054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lehmann, J. Horcher, K. Dennig, A. Plewan, K. Ulm, and E. Alt Atrial Mechanical Performance After Internal and External Cardioversion of Atrial Fibrillation : An Echocardiographic Study Chest, January 1, 2002; 121(1): 13 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Schluter, H. Baum, A. Plewan, and D. Neumeier Effects of Implantable Cardioverter Defibrillator Implantation and Shock Application on Biochemical Markers of Myocardial Damage Clin. Chem., March 1, 2001; 47(3): 459 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Jaffe, J. Ravkilde, R. Roberts, U. Naslund, F. S. Apple, M. Galvani, and H. Katus It's Time for a Change to a Troponin Standard Circulation, September 12, 2000; 102(11): 1216 - 1220. [Full Text] [PDF]
|
|
|
|
|
|
G. Boriani, M. Biffi, V. Cervi, G. Bronzetti, G. Magagnoli, R. Zannoli, and A. Branzi Evaluation of Myocardial Injury Following Repeated Internal Atrial Shocks by Monitoring Serum Cardiac Troponin I Levels Chest, August 1, 2000; 118(2): 342 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.A. Morrow and E.M. Antman Cardiac marker elevation after cardioversion: sorting out chicken and egg Eur. Heart J., February 1, 2000; 21(3): 171 - 173. [PDF]
|
|
|
|
|
|
M Lund, J.K French, R.N Johnson, B.F Williams, and H.D White Serum troponins T and I after elective cardioversion Eur. Heart J., February 1, 2000; 21(3): 245 - 253. [Abstract] [PDF]
|
|
|
|
|
|
T. M. Hurst, M. Hinrichs, C. Breidenbach, N. Katz, and B. Waldecker Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators J. Am. Coll. Cardiol., August 1, 1999; 34(2): 402 - 408. [Abstract] [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
